Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Recommendation for optimal management of severe refractory asthma.

Morjaria JB, Polosa R.

J Asthma Allergy. 2010 Jul 26;3:43-56.

2.

Omalizumab for asthma in adults and children.

Normansell R, Walker S, Milan SJ, Walters EH, Nair P.

Cochrane Database Syst Rev. 2014 Jan 13;(1):CD003559. doi: 10.1002/14651858.CD003559.pub4. Review.

PMID:
24414989
3.

Immunomodulatory and biologic therapies for severe refractory asthma.

Polosa R, Morjaria J.

Respir Med. 2008 Nov;102(11):1499-510. doi: 10.1016/j.rmed.2008.09.006. Review.

4.

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty.

Menzella F, Galeone C, Lusuardi M, Simonazzi A, Castagnetti C, Ruggiero P, Facciolongo N.

Ther Clin Risk Manag. 2017 Nov 8;13:1489-1493. doi: 10.2147/TCRM.S149775. eCollection 2017.

5.

Pharmacotherapy of severe asthma.

Firszt R, Kraft M.

Curr Opin Pharmacol. 2010 Jun;10(3):266-71. doi: 10.1016/j.coph.2010.04.010. Epub 2010 May 10. Review.

6.

Managing patients with chronic severe asthma: rise to the challenge.

Polosa R, Benfatto GT.

Eur J Intern Med. 2009 Mar;20(2):114-24. doi: 10.1016/j.ejim.2008.06.010. Epub 2008 Aug 9. Review.

PMID:
19327598
7.
8.

Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.

Norman G, Faria R, Paton F, Llewellyn A, Fox D, Palmer S, Clifton I, Paton J, Woolacott N, McKenna C.

Health Technol Assess. 2013 Nov;17(52):1-342. doi: 10.3310/hta17520. Review.

9.

Interventions for managing asthma in pregnancy.

Bain E, Pierides KL, Clifton VL, Hodyl NA, Stark MJ, Crowther CA, Middleton P.

Cochrane Database Syst Rev. 2014 Oct 21;(10):CD010660. doi: 10.1002/14651858.CD010660.pub2. Review.

PMID:
25331331
10.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
11.

Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.

Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD005533. doi: 10.1002/14651858.CD005533.pub2. Review.

12.

Severe asthma: advances in current management and future therapy.

Barnes PJ.

J Allergy Clin Immunol. 2012 Jan;129(1):48-59. doi: 10.1016/j.jaci.2011.11.006. Review.

PMID:
22196524
13.

Severe asthma: future treatments.

O'Byrne PM, Naji N, Gauvreau GM.

Clin Exp Allergy. 2012 May;42(5):706-11. doi: 10.1111/j.1365-2222.2012.03965.x. Review.

PMID:
22515391
14.

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD005535.

PMID:
16235410
15.

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.

Kew KM, Karner C, Mindus SM, Ferrara G.

Cochrane Database Syst Rev. 2013 Dec 16;(12):CD009019. doi: 10.1002/14651858.CD009019.pub2. Review.

PMID:
24343671
16.

Challeges in the management of severe asthma: role of current and future therapies.

Oliveinstein R, Al Jahdali H, Alkhamis N, Halwani R, Al-Muhsen S, Hamid Q.

Curr Pharm Des. 2011;17(7):703-11. Review.

PMID:
21406058
17.

Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.

Sin DD, Man J, Sharpe H, Gan WQ, Man SF.

JAMA. 2004 Jul 21;292(3):367-76. Review.

PMID:
15265853
18.

Monoclonal antibodies for the treatment of refractory asthma.

Hambly N, Nair P.

Curr Opin Pulm Med. 2014 Jan;20(1):87-94. doi: 10.1097/MCP.0000000000000007. Review.

PMID:
24275927
19.

Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids.

Domingo C, Moreno A, Mirapeix R.

Intern Med J. 2011 Jul;41(7):525-36. doi: 10.1111/j.1445-5994.2011.02481.x. Review.

PMID:
21762333
20.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.

Anderson DE, Kew KM, Boyter AC.

Cochrane Database Syst Rev. 2015 Aug 24;(8):CD011397. doi: 10.1002/14651858.CD011397.pub2. Review.

PMID:
26301488

Supplemental Content

Support Center